경장영양 제제 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 플로우 유형별, 스테이지별, 적응증별, 최종 용도별, 판매채널별, 지역별, 부문 예측(2025-2030년)

Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End-user, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,641,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,094,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,998,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

경장영양제 시장 성장 및 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 경장영양 제제 시장 규모는 2025-2030년 동안 CAGR 5.43%를 기록하며 2030년에는 105억 2,000만 달러에 달할 것으로 예측됩니다.

대상 질환 증가와 의약품 개발의 발전으로 인해 질환별 배합에 대한 수요가 증가할 것으로 예측됩니다. 임상영양학은 암, 낭포성 섬유증과 같은 질환의 맞춤형 치료에 점점 더 많이 사용되고 있습니다. 이러한 질병은 모든 유형의 약물 상호 작용을 피하기 위해 특별한 영양이 필요합니다.

예를 들어 자궁축농증의 경우 특수 소화효소 캡슐을 투여합니다. 이러한 소화 효소의 특성은 개인차가 있습니다. 조산아에게 적절한 영양 공급은 매우 중요하며, 조기 영양 공급은 신경 발달, 미숙아 망막증(ROP) 위험 감소, 기관지폐이형성증(BPD) 예방 등 더 나은 임상 결과와 아이의 성장에 영향을 미칠 수 있습니다.

유엔의 'Every Woman Every Child' 운동 등 여성 및 아동 건강 관련 세계 전략을 추진하는 NPO 및 NGO의 조산 예방 치료 노력은 신생아 및 조산아를 위한 장내 영양제 수요를 증가시킬 것으로 예측됩니다. 환자들 사이에서 영양소의 중요성에 대한 인식 확산 노력이 확대되고 있으며, 현재의 시장 시나리오가 개선될 것으로 예측됩니다.

ASPEN이 발표한 'ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week(ASPEN은 매년 영양실조 인식주간을 통해 진단, 진료, 치료의 심각한 격차를 해소하기 위해 노력합니다. (ASPEN은 매년 영양실조 인식 주간을 통해 진단, 관리, 치료의 심각한 격차를 해소하기 위해 노력한다)"라는 기사에 따르면 입원 환자 중 약 10명이 60초마다 진단을 받지 못하고 있다고 합니다. 이에 이 단체는 입원환자의 영양실조에 대한 인식을 높이고, 의료 전문가들에게 환자 영양의 중요성에 대해 교육하기 위해 2011년에 영양실조 인식개선 주간을 제정했습니다.

의료적 필요성이 있는 경우, 메디케이드는 경장영양을 보장해야 합니다. 그러나 민간 보험사에는 그러한 규제나 의무가 없습니다. 또한 NCBI가 실시한 조사 결과에 따르면 재택 경장영양(HEN) 환자에 대한 상환이 크게 부족하고, 특히 저소득 국가에서 시장 기회에 대한 이해 관계자의 인식이 부족합니다.

경장영양제 시장 보고서 하이라이트

• 표준 포뮬러 부문은 2024년 53.7%의 매출 점유율로 시장을 선도했습니다. 질병별 포뮬러 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 간헐적 공급 흐름 부문은 2024년에 가장 큰 매출 점유율을 차지했습니다. 연속 공급 흐름 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 성인 부문은 2024년에 가장 큰 시장 매출 점유율을 차지했습니다. 또한 성인 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 2024년 시장 매출 점유율은 암 치료 부문이 최대였습니다. 기타 적응증 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 2024년 시장 매출 점유율은 시설 판매 부문이 최대였습니다. 온라인 유통 채널 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
• 재택 간호 부문은 2024년 가장 큰 시장 매출 점유율을 차지했습니다. 병원 부문은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 경장영양 제제 시장의 변수, 동향, 범위

• 시장 계통 전망
• 산업 분석
  • 사용자의 시점 분석
  • 주요 최종사용자
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 산업의 과제
• 경장영양 제제 시장 분석 툴
  • 경장영양 기구 시장 - PESTLE 분석
  • 산업 분석 - Porter's Five Forces 분석
• COVID-19에 의한 경장영양 제제 시장에 대한 영향

제4장 경장영양 제제 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 제품 변동 분석, 2023년과 2030년
  • 표준식
  • 질환 특이적 배합

제5장 경장영양 제제 시장 : 플로우 유형별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 플로우 유형 변동 분석, 2023년과 2030년
  • 간헐 공급 플로우
  • 상용 공급 플로우

제6장 경장영양 제제 시장 : 스테이지별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 스테이지 변동 분석, 2023년과 2030년
• 성인
• 소아

제7장 경장영양 제제 시장 : 적응증별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 적응증 변동 분석, 2023년과 2030년
  • 알츠하이머병
  • 영양 부족
  • 암치료
  • 당뇨병
  • 만성 신장병
  • 희귀질환
  • 연하장애
  • 통증 관리
  • 흡수 불량/소화관 장애/설사
  • 기타

제8장 경장영양 제제 시장 : 최종사용자별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 최종사용자 변동 분석, 2023년과 2030년
  • 병원
  • 홈케어

제9장 경장영양 제제 시장 : 판매채널별, 추정·동향 분석

• 부문 대시보드
• 경장영양 제제 시장 : 판매채널 변동 분석, 2023년과 2030년
  • 온라인
  • 소매
  • 시설 판매

제10장 경장영양 제제 시장 : 지역별, 추정·동향 분석

• 경장영양 제제 시장 : 지역 변동 분석, 2023년과 2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제11장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업 분류
• 벤더 구도
  • 주요 고객
• 주요 기업의 시장 점유율 분석
• 기업의 시장 현황 분석
• 기업 시장 순위
  • 지역 네트워크 맵
• 기업 개요/상장기업
  • Abbott
  • Danone SA
  • Fresenius Kabi AG
  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Mead Johnson & Company, LLC
  • Alcresta Therapeutics

KSA

영문 목차

영문목차

Enteral Feeding Formulas Market Growth & Trends:

The global enteral feeding formulas market size is expected to reach USD 10.52 billion by 2030, registering a CAGR of 5.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is increasingly used for the personalized treatment of diseases, such as cancer and cystic fibrosis. These conditions require special nutrition to avoid any kind of drug interaction.

For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of these digestive enzymes can vary in individuals. Appropriate nutrition is critical for preterm infants, and early nutrition provision could influence better clinical outcomes & growth of the child, including neurodevelopment, decreased risk of Retinopathy of Prematurity (ROP), or prevention of Bronchopulmonary Dysplasia (BPD).

The commitment of NPOs and NGOs to preventing and caring for preterm birth, such as the 'Every Woman Every Child' movement of the UN, to advance the global strategy on women's and children's health, is expected to boost the demand for neonatal & preterm enteral feeding formulas. Growing initiatives to spread awareness regarding the importance of nutrients among the patient population are expected to improve the current market scenario.

According to an article titled ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week, published by ASPEN, around 10 hospitalized patients go undiagnosed every 60 seconds. Hence, this organization established Malnutrition Awareness Week in 2011 to spread awareness regarding malnutrition in hospitalized patients and educate healthcare professionals on the importance of nutrients among patients.

In case of medical necessity, Medicaid must cover enteral nutrition. However, there are no such regulations/mandates on private insurance companies. Moreover, as per the results of a survey conducted by NCBI, there is a huge lack of reimbursement for patients on Home Enteral Nutrition (HEN) and inadequate awareness among stakeholders regarding market opportunities, especially in lower-income countries.

Enteral Feeding Formulas Market Report Highlights:

• The standard formula segment led the market with the largest revenue share of 53.7% in 2024. The disease-specific formulas segment is expected to grow at the fastest CAGR during the forecast period.
• The intermittent feeding flow segment accounted for the largest revenue share in 2024. The continuous feeding flow segment is anticipated to grow at the fastest CAGR during the forecast period.
• The adult segment accounted for the largest market revenue share in 2024. The adult segment is also projected to grow at the fastest CAGR during the forecast period.
• The cancer care segment accounted for the largest market revenue share in 2024. The other indications segment is expected to grow at the fastest CAGR over the forecast period.
• The institutional sales segment accounted for the largest market revenue share in 2024. The online sales channel segment is projected to grow at the fastest CAGR over the forecast period.
• The home care segment accounted for the largest market revenue share in 2024. The hospital segment is anticipated to grow at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
  • 1.2.1. Information Procurement
• 1.3. Information or Data Analysis
• 1.4. Research Models
  • 1.4.1. Market Formulation & Validation
    • 1.4.1.1. Country Market: CAGR Calculation
  • 1.4.2. Country-based Segment Share Calculation
• 1.5. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Enteral Feeding Formulas Market Snapshot
• 2.2. Enteral Feeding Formulas Market Segment Snapshot
• 2.3. Enteral Feeding Formulas Market Competitive Landscape Snapshot

Chapter 3. Enteral Feeding Formulas Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
    • 3.2.1.1. Consumer Behavior Analysis
    • 3.2.1.2. Product Placement Framework
    • 3.2.1.3. Market Influencer Analysis
  • 3.2.2. Key End Users
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising geriatric population
    • 3.3.1.2. Growing prevalence of chronic diseases
    • 3.3.1.3. Shifting trend toward consumption of disease-specific formulas
    • 3.3.1.4. Growing demand for neonatal and preterm enteral feeding
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of awareness in the medical community
    • 3.3.2.2. Improper categorization of clinical nutrition
  • 3.3.3. Industry Challenges
    • 3.3.3.1. Complications associated with small-bore connectors
    • 3.3.3.2. Risks associated with enteral feeding
• 3.4. Enteral Feeding Formulas Market Analysis Tools
  • 3.4.1. Enteral Feeding Devices Market - Pestle Analysis
  • 3.4.2. Industry Analysis - Porter's Five Forces
• 3.5. COVID-19 Impact on Enteral Feeding Formulas Market

Chapter 4. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2.1. Standard Formula
    • 4.2.1.1. Standard Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Disease-specific Formula
    • 4.2.2.1. Disease-specific Formula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2.2. Alzheimer's Disease
      • 4.2.2.2.1. Disease Specific Formulas Market Estimates And Forecasts, For Alzheimer's Disease, 2018 - 2030 (USD Million)
    • 4.2.2.3. Nutrition Deficiency
      • 4.2.2.3.1. Disease Specific Formulas Market Estimates And Forecasts, For Nutrition Deficiency, 2018 - 2030 (USD Million)
    • 4.2.2.4. Cancer Care
      • 4.2.2.4.1. Disease Specific Formulas Market Estimates And Forecasts, For Cancer Care, 2018 - 2030 (USD Million)
    • 4.2.2.5. Diabetes
      • 4.2.2.5.1. Disease Specific Formulas Market Estimates And Forecasts, For Diabetes, 2018 - 2030 (USD Million)
    • 4.2.2.6. Chronic Kidney Diseases
      • 4.2.2.6.1. Disease Specific Formulas Market Estimates And Forecasts, For Chronic Kidney Diseases, 2018 - 2030 (USD Million)
    • 4.2.2.7. Orphan Diseases
      • 4.2.2.7.1. Disease Specific Formulas Market Estimates And Forecasts, For Orphan Diseases, 2018 - 2030 (USD Million)
    • 4.2.2.8. Dysphagia
      • 4.2.2.8.1. Disease Specific Formulas Market Estimates And Forecasts, For Dysphagia, 2018 - 2030 (USD Million)
    • 4.2.2.9. Pain Management
      • 4.2.2.9.1. Disease Specific Formulas Market Estimates And Forecasts, For Pain Management, 2018 - 2030 (USD Million)
    • 4.2.2.10. Malabsorption/GI Disorder/Diarrhea
      • 4.2.2.10.1. Disease Specific Formulas Market Estimates And Forecasts, For Malabsorption/GI Disorder/Diarrhea, 2018 - 2030 (USD Million)
    • 4.2.2.11. Others
      • 4.2.2.11.1. Disease Specific Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)

Chapter 5. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.2.1. Intermittent Feeding Flow
    • 5.2.1.1. Intermittent Feeding Flow Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Continuous Feeding Flow
    • 5.2.2.1. Continuous Feeding Flow Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
• 6.3. Adult
  • 6.3.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Pediatric
  • 6.4.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 7.2.1. Alzheimer's Disease
    • 7.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Alzheimer's Disease, 2018 - 2030 (USD Million)
  • 7.2.2. Nutrition Deficiency
    • 7.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Nutrition Deficiency, 2018 - 2030 (USD Million)
  • 7.2.3. Cancer Care
    • 7.2.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Cancer Care, 2018 - 2030 (USD Million)
  • 7.2.4. Diabetes
    • 7.2.4.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Diabetes, 2018 - 2030 (USD Million)
  • 7.2.5. Chronic Kidney Diseases
    • 7.2.5.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Chronic Kidney Diseases, 2018 - 2030 (USD Million)
  • 7.2.6. Orphan Diseases
    • 7.2.6.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Orphan Diseases, 2018 - 2030 (USD Million)
  • 7.2.7. Dysphagia
    • 7.2.7.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Dysphagia, 2018 - 2030 (USD Million)
  • 7.2.8. Pain Management
    • 7.2.8.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Pain Management, 2018 - 2030 (USD Million)
  • 7.2.9. Malabsorption/GI Disorder/Diarrhea
    • 7.2.9.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Malabsorption/Gi Disorder/Diarrhea, 2018 - 2030 (USD Million)
  • 7.2.10. Others
    • 7.2.10.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)

Chapter 8. Enteral Feeding Formulas Market: End User Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Enteral Feeding Formulas Market: End User Movement Analysis, 2023 & 2030 (USD Million)
  • 8.2.1. Hospitals
    • 8.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Hospitals, 2018 - 2030 (USD Million)
    • 8.2.1.2. Cardiology
      • 8.2.1.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Cardiology, 2018 - 2030 (USD Million)
    • 8.2.1.3. Neurology
      • 8.2.1.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Neurology, 2018 - 2030 (USD Million)
    • 8.2.1.4. Critical Care (ICU)
      • 8.2.1.4.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Critical Care (ICU), 2018 - 2030 (USD Million)
    • 8.2.1.5. Oncology
      • 8.2.1.5.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Oncology, 2018 - 2030 (USD Million)
    • 8.2.1.6. Others
      • 8.2.1.6.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Others, 2018 - 2030 (USD Million)
  • 8.2.2. Home Care
    • 8.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Home Care, 2018 - 2030 (USD Million)

Chapter 9. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 9.2.1. Online
    • 9.2.1.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Online Sales Channel, 2018 - 2030 (USD Million)
  • 9.2.2. Retail
    • 9.2.2.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Retail Sales Channel, 2018 - 2030 (USD Million)
  • 9.2.3. Institutional Sales
    • 9.2.3.1. Enteral Feeding Formulas Market Estimates And Forecasts, For Institutional Sales Channel, 2018 - 2030 (USD Million)

Chapter 10. Enteral Feeding Formulas Market: Regional Estimates & Trend Analysis

• 10.1. Enteral Feeding Formulas Market: Regional Movement Analysis, 2023 & 2030
• 10.2. North America
  • 10.2.1. North America Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.2. U.S.
    • 10.2.2.1. Key Country Dynamics
    • 10.2.2.2. Prevalence Insights
    • 10.2.2.3. Regulatory Framework
    • 10.2.2.4. U.S. Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.3. Canada
    • 10.2.3.1. Key Country Dynamics
    • 10.2.3.2. Prevalence Insights
    • 10.2.3.3. Regulatory Framework
    • 10.2.3.4. Canada Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.2.4. Mexico
    • 10.2.4.1. Key Country Dynamics
    • 10.2.4.2. Prevalence Insights
    • 10.2.4.3. Regulatory Framework
    • 10.2.4.4. Mexico Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.3. Europe
  • 10.3.1. Europe Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.2. UK
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Prevalence Insights
    • 10.3.2.3. Regulatory Framework
    • 10.3.2.4. UK Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.3. Germany
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Prevalence Insights
    • 10.3.3.3. Regulatory Framework
    • 10.3.3.4. Germany Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.4. France
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Prevalence Insights
    • 10.3.4.3. Regulatory Framework
    • 10.3.4.4. France Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.5. Italy
    • 10.3.5.1. Key Country Dynamics
    • 10.3.5.2. Prevalence Insights
    • 10.3.5.3. Regulatory Framework
    • 10.3.5.4. Italy Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.6. Spain
    • 10.3.6.1. Key Country Dynamics
    • 10.3.6.2. Prevalence Insights
    • 10.3.6.3. Regulatory Framework
    • 10.3.6.4. Spain Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.7. Denmark
    • 10.3.7.1. Key Country Dynamics
    • 10.3.7.2. Prevalence Insights
    • 10.3.7.3. Regulatory Framework
    • 10.3.7.4. Denmark Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.8. Sweden
    • 10.3.8.1. Key Country Dynamics
    • 10.3.8.2. Prevalence Insights
    • 10.3.8.3. Regulatory Framework
    • 10.3.8.4. Sweden Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.3.9. Norway
    • 10.3.9.1. Key Country Dynamics
    • 10.3.9.2. Prevalence Insights
    • 10.3.9.3. Regulatory Framework
    • 10.3.9.4. Norway Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.4. Asia Pacific
  • 10.4.1. Asia Pacific Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.2. Japan
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Prevalence Insights
    • 10.4.2.3. Regulatory Framework
    • 10.4.2.4. Japan Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.3. China
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Prevalence Insights
    • 10.4.3.3. Regulatory Framework
    • 10.4.3.4. China Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.4. India
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Prevalence Insights
    • 10.4.4.3. Regulatory Framework
    • 10.4.4.4. India Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.5. South Korea
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Prevalence Insights
    • 10.4.5.3. Regulatory Framework
    • 10.4.5.4. South Korea Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.6. Australia
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Prevalence Insights
    • 10.4.6.3. Regulatory Framework
    • 10.4.6.4. Australia Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.4.7. Thailand
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Prevalence Insights
    • 10.4.7.3. Regulatory Framework
    • 10.4.7.4. Thailand Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.5. Latin America
  • 10.5.1. Latin America Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5.2. Brazil
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Prevalence Insights
    • 10.5.2.3. Regulatory Framework
    • 10.5.2.4. Brazil Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5.3. Argentina
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Prevalence Insights
    • 10.5.3.3. Regulatory Framework
    • 10.5.3.4. Argentina Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 10.6. Middle East & Africa
  • 10.6.1. Middle East & Africa Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.2. South Africa
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Prevalence Insights
    • 10.6.2.3. Regulatory Framework
    • 10.6.2.4. South Africa Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.3. Saudi Arabia
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Prevalence Insights
    • 10.6.3.3. Regulatory Framework
    • 10.6.3.4. Saudi Arabia Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.4. UAE
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Prevalence Insights
    • 10.6.4.3. Regulatory Framework
    • 10.6.4.4. UAE Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.6.5. Kuwait
    • 10.6.5.1. Key Country Dynamics
    • 10.6.5.2. Prevalence Insights
    • 10.6.5.3. Regulatory Framework
    • 10.6.5.4. Kuwait Enteral Feeding Formulas Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis, By Key Market Participants
• 11.2. Company Categorization
• 11.3. Vendor Landscape
  • 11.3.1. Key Customers
• 11.4. Key Company Market Share Analysis
• 11.5. Company Market Position Analysis
• 11.6. Company Market Ranking
  • 11.6.1. Regional Network Map
• 11.7. Company Profiles/Listing
  • 11.7.1. Abbott
    • 11.7.1.1. Overview
    • 11.7.1.2. Financial Performance (Net Revenue)
    • 11.7.1.3. Product Benchmarking
    • 11.7.1.4. Strategic Initiatives
  • 11.7.2. Danone S.A
    • 11.7.2.1. Overview
    • 11.7.2.2. Financial Performance (Net Revenue)
    • 11.7.2.3. Product Benchmarking
    • 11.7.2.4. Strategic Initiatives
  • 11.7.3. Fresenius Kabi AG
    • 11.7.3.1. Overview
    • 11.7.3.2. Financial Performance (Net Revenue)
    • 11.7.3.3. Product Benchmarking
    • 11.7.3.4. Strategic Initiatives
  • 11.7.4. Nestle
    • 11.7.4.1. Overview
    • 11.7.4.2. Financial Performance (Net Revenue)
    • 11.7.4.3. Product Benchmarking
    • 11.7.4.4. Strategic Initiatives
  • 11.7.5. VICTUS
    • 11.7.5.1. Overview
    • 11.7.5.2. Financial Performance (Net Revenue)
    • 11.7.5.3. Product Benchmarking
    • 11.7.5.4. Strategic Initiatives
  • 11.7.6. Primus Pharmaceuticals, Inc.
    • 11.7.6.1. Overview
    • 11.7.6.2. Financial Performance (Net Revenue)
    • 11.7.6.3. Product Benchmarking
    • 11.7.6.4. Strategic Initiatives
  • 11.7.7. Meiji Holdings. Co., Ltd.
    • 11.7.7.1. Overview
    • 11.7.7.2. Financial Performance (Net Revenue)
    • 11.7.7.3. Product Benchmarking
    • 11.7.7.4. Strategic Initiatives
  • 11.7.8. Mead Johnson & Company, LLC
    • 11.7.8.1. Overview
    • 11.7.8.2. Financial Performance (Net Revenue)
    • 11.7.8.3. Product Benchmarking
    • 11.7.8.4. Strategic Initiatives
  • 11.7.9. Alcresta Therapeutics
    • 11.7.9.1. Overview
    • 11.7.9.2. Financial Performance (Net Revenue)
    • 11.7.9.3. Product Benchmarking
    • 11.7.9.4. Strategic Initiatives

관련자료